Table 3 Long-term survival (LTS) versus Short-term survival (STS)
From: Developments in esophageal surgery for adenocarcinoma: a comparison of two decades
|  | Decade I (9/1985–9/1995) (n = 48) | Decade II (10/1995–9/2005) (n = 127) | ||
|---|---|---|---|---|
| Â | LTS/STS | p-value | LTS/STS | p-value |
age (years) | 64.3/60.8 | n.s. | 61.9/63.3 | n.s. |
ASA (%) | Â | Â | Â | Â |
-ASA I | 0 | Â | 0 | Â |
-ASA II | 28/33.3 | n.s. | 49.2/46.8 | n.s. |
-ASA III | 60/57.1 | Â | 49.2/51.6 | Â |
-ASA IV | 12/9.5 | Â | 1.7/1.6 | Â |
operative approach (%) | Â | Â | Â | Â |
-transhiatal | 34.6/31.8 | n.s. | 88.7/80 | n.s. |
-transthoracic | 65.4/68.2 | Â | 11.3/20 | Â |
UICC-classification (%) | Â | Â | Â | Â |
-I | 23.1/0 | Â | 26.2/3.1 | Â |
-IIA | 30.8/4.8 | Â | 19.7/10.8 | Â |
-IIB | 0 | 0.004* | 23/15.4 | <0.0001* |
-III | 23.1/57.1 | Â | 16.4/30.8 | Â |
-IV | 23.1/38.1 | Â | 14.8/40 | Â |
R-classification (%) | Â | Â | Â | Â |
-R1 | 84.6/81.8 | n.s. | 93.5/89.1 | n.s. |
-R2 | 7.7/18.2 | Â | 6.5/9.4 | Â |
-R3 | 7.7/0 | Â | 0/1.6 | Â |